BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23067089)

  • 1. Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial.
    Sonthalia S; Singal A
    Int J Dermatol; 2012 Nov; 51(11):1371-8. PubMed ID: 23067089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus.
    Radfar L; Wild RC; Suresh L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):187-93. PubMed ID: 18230389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus.
    Corrocher G; Di Lorenzo G; Martinelli N; Mansueto P; Biasi D; Nocini PF; Lombardo G; Fior A; Corrocher R; Bambara LM; Gelio S; Pacor ML
    J Clin Periodontol; 2008 Mar; 35(3):244-9. PubMed ID: 18269664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
    Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
    Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: A double-blinded, randomized clinical trial in Sri Lanka.
    Hettiarachchi PVKS; Hettiarachchi RM; Jayasinghe RD; Sitheeque M
    J Investig Clin Dent; 2017 Nov; 8(4):. PubMed ID: 27633647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
    Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
    Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment.
    Laeijendecker R; Tank B; Dekker SK; Neumann HA
    Acta Derm Venereol; 2006; 86(3):227-9. PubMed ID: 16710580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial.
    Lodi G; Tarozzi M; Sardella A; Demarosi F; Canegallo L; Di Benedetto D; Carrassi A
    Br J Dermatol; 2007 Jun; 156(6):1336-41. PubMed ID: 17535232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index.
    Pothinamthong P; Janjumratsang P
    J Med Assoc Thai; 2012 Jul; 95(7):933-40. PubMed ID: 22919989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial.
    Conrotto D; Carbone M; Carrozzo M; Arduino P; Broccoletti R; Pentenero M; Gandolfo S
    Br J Dermatol; 2006 Jan; 154(1):139-45. PubMed ID: 16403107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations.
    Carbone M; Arduino PG; Carrozzo M; Caiazzo G; Broccoletti R; Conrotto D; Bezzo C; Gandolfo S
    J Oral Pathol Med; 2009 Feb; 38(2):227-33. PubMed ID: 19141065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial.
    Vohra S; Singal A; Sharma SB
    Int J Dermatol; 2016 Jan; 55(1):101-5. PubMed ID: 26147635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo.
    Ho N; Pope E; Weinstein M; Greenberg S; Webster C; Krafchik BR
    Br J Dermatol; 2011 Sep; 165(3):626-32. PubMed ID: 21457214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma in a patient with oral lichen planus treated with topical application of tacrolimus.
    Mattsson U; Magnusson B; Jontell M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):e19-25. PubMed ID: 20610291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
    Gorouhi F; Solhpour A; Beitollahi JM; Afshar S; Davari P; Hashemi P; Nassiri Kashani M; Firooz A
    J Am Acad Dermatol; 2007 Nov; 57(5):806-13. PubMed ID: 17658663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus.
    Hodgson TA; Sahni N; Kaliakatsou F; Buchanan JA; Porter SR
    Eur J Dermatol; 2003; 13(5):466-70. PubMed ID: 14693491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimecrolimus vs. tacrolimus for the topical treatment of unresponsive oral erosive lichen planus: a 8 week randomized double-blind controlled study.
    Arduino PG; Carbone M; Della Ferrera F; Elia A; Conrotto D; Gambino A; Comba A; Calogiuri PL; Broccoletti R
    J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):475-82. PubMed ID: 23451852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory erosive oral lichen planus associated with hepatitis C: response to topical tacrolimus ointment.
    Donovan JC; Hayes RC; Burgess K; Leong IT; Rosen CF
    J Cutan Med Surg; 2005 Apr; 9(2):43-6. PubMed ID: 16392010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.